Filing Details
- Accession Number:
- 0001468429-17-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-29 16:01:32
- Reporting Period:
- 2016-11-02
- Filing Date:
- 2017-03-29
- Accepted Time:
- 2017-03-29 16:01:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1024626 | Cannabis Science Inc. | CBIS | Pharmaceutical Preparations (2834) | 911869677 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1596722 | James Robert Kane | 11525 Texarkanna Road Peyton CO 80831 | Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-11-02 | 1,000,000 | $0.06 | 12,936,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-11-02 | 500,000 | $0.06 | 12,436,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-01-11 | 500,000 | $0.07 | 11,936,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-01-13 | 500,000 | $0.07 | 11,436,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-01-18 | 1,000,000 | $0.09 | 10,436,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-02-01 | 952,525 | $0.11 | 9,483,960 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-02-01 | 47,475 | $0.12 | 9,436,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-02-21 | 300,000 | $0.12 | 9,136,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-02-21 | 400,000 | $0.12 | 8,736,485 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |